OR5M10

Across TCGA pan-cancer cohorts, OR5M10 Mutation is linked to patient survival in 4 of 34 cancer types, making it a survival-associated OR5M10 data layer compared with 7 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher OR5M10 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated OR5M10 expression acts as an unfavorable survival marker, although some lineages such as UCEC show a favorable association.

LUAD, UCEC, and LIHC are the cancer types where OR5M10 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	All	0.436	0.844	<.001	25	view →
UCEC	DFS	Median	All	1.000	0.625	.029	12	view →
LIHC	OS	Median	II,III,IV	0.118	0.716	.003	12	view →
COAD	OS	Median	All	0.160	0.613	.030	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

OR5M10–LUAD (OS)

Open the LUAD breakdown →